Sequence and comparative analysis of the genome of HSV-1 strain McKrae

Virology

Volumn 433, Issue 2, 2012, Pages 528-537

  Watson, G ^a   Xu, W ^b,c   Reed, A ^a   Babra, B ^a   Putman, T ^a   Wick, E ^a   Wechsler, S L ^d,e   Rohrmann, G F ^a   Jin, L ^a  

^a OREGON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c University of Minnesota ^*  (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

DNA sequence comparison; Herpes virus; High throughput DNA sequencing

Indexed keywords

LAT PROTEIN; MICRORNA; PROTEIN US11; RETINOSCHISIN; RL1 PROTEIN; UL36 PROTEIN; UL49A PROTEIN; UL56 PROTEIN; UNCLASSIFIED DRUG; US10 PROTEIN; US7 PROTEIN; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; GENE SEQUENCE; GENETIC CODE; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; STRAIN DIFFERENCE; VIRUS GENOME; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CONSERVED SEQUENCE; DNA, VIRAL; GENETIC VARIATION; GENOME, VIRAL; HERPESVIRUS 1, HUMAN; INVERTED REPEAT SEQUENCES; MICE; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; RABBITS; REPLICATION ORIGIN; SEQUENCE HOMOLOGY, AMINO ACID; SPECIES SPECIFICITY; TANDEM REPEAT SEQUENCES; VIRAL PROTEINS; VIRULENCE;

ANIMALIA; HERPESVIRIDAE; HUMAN HERPESVIRUS 1; MUS; ORYCTOLAGUS CUNICULUS;

EID: 84867213783     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2012.08.043     Document Type: Article

References (51)

1. Balan P., Davis-Poynter N., Bell S., Atkinson H., Browne H., Minson T. An analysis of the in vitro and in vivo phenotypes of mutants of herpes simplex virus type 1 lacking glycoproteins gG, gE, gI or the putative gJ. J. Gen. Virol. 1994, 75(6):1245-1258.
2. Balliet, J.W., Schaffer, P.A., 2006, Point Mutations in Herpes Simplex Virus Type 1 oriL, But Not in oriS, Reduce Pathogenesis During Acute Infection of Mice and Impair Reactivation From Latency, In: J. Virol. United States, pp. 440-450.
3. Block T.M., Deshmane S., Masonis J., Maggioncalda J., Valyi-Nagi T., Fraser N.W. An HSV LAT null mutant reactivates slowly from latent infection and makes small plaques on CV-1 monolayers. Virology 1993, 192:618-630.
4. Bolovan C.A., Sawtell N.M., Thompson R.L. ICP34.5 mutants of herpes simplex virus type 1 strain 17syn+ are attenuated for neurovirulence in mice and for replication in confluent primary mouse embryo cell cultures. J. Virol. 1994, 68:48-55.
5. Bower J.R., Mao H., Durishin C., Rozenbom E., Detwiler M., Rempinski D., Karban T.L., Rosenthal K.S. Intrastrain variants of herpes simplex virus type 1 isolated from a neonate with fatal disseminated infection differ in the ICP34.5 gene, glycoprotein processing, and neuroinvasiveness. J. Virol. 1999, 73:3843-3853.
6. Browne H., Bruun B., Minson T. Plasma membrane requirements for cell fusion induced by herpes simplex virus type 1 glycoproteins gB, gD, gH and gL. J. Gen. Virol. 2001, 82:1419-1422.
7. Chou J., Roizman B. The terminal a sequence of the herpes simplex virus genome contains the promoter of a gene located in the repeat sequences of the L component. J. Virol. 1986, 57:629-637.
8. Desai P.J. A null mutation in the UL36 gene of herpes simplex virus type 1 results in accumulation of unenveloped DNA-filled capsids in the cytoplasm of infected cells. J. Virol. 2000, 74:11608-11618.
9. Halford W.P., Kemp C.D., Isler J.A., Davido D.J., Schaffer P.A. ICP0, ICP4, or VP16 expressed from adenovirus vectors induces reactivation of latent herpes simplex virus type 1 in primary cultures of latently infected trigeminal ganglion cells. J. Virol. 2001, 75:6143-6153.
10. Halford W.P., Schaffer P.A. ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency. J. Virol. 2001, 75:3240-3249.
11. Hardwicke M.A., Schaffer P.A. Differential effects of nerve growth factor and dexamethasone on herpes simplex virus type 1 oriL-and oriS-dependent DNA replication in PC12 cells. J. Virol. 1997, 71:3580. 3580.
12. Hill J.M., Gebhardt B.M., Wen R., Bouterie A.M., Thompson H.W., O'Callaghan R.J., Halford W.P., Kaufman H.E. Quantitation of herpes simplex virus type 1 DNA and latency-associated transcripts in rabbit trigeminal ganglia demonstrates a stable reservoir of viral nucleic acids during latency. J. Virol. 1996, 70:3137-3141.
13. Hill J.M., Rayfield M.A., Haruta Y. Strain specificity of spontaneous and adrenergically induced HSV-1 ocular reactivation in latently infected rabbits. Curr. Eye Res. 1987, 6:91-97.
14. Hill J.M., Sedarati F., Javier R.T., Wagner E.K., Stevens J.G. Herpes simplex virus latent phase transcription facilitates in vivo reactivation. Virology 1990, 174:117-125.
15. Jin L., Perng G.C., Carpenter D., Mott K.R., Osorio N., Naito J., Brick D.J., Jones C., Wechsler S.L. Reactivation phenotype in rabbits of a herpes simplex virus type 1 mutant containing an unrelated antiapoptosis gene in place of latency-associated transcript. J. Neurovirol. 2007, 13:78-84.
16. Jin L., Perng G.C., Mott K.R., Osorio N., Naito J., Brick D.J., Carpenter D., Jones C., Wechsler S.L. A herpes simplex virus type 1 mutant expressing a baculovirus inhibitor of apoptosis gene in place of latency-associated transcript has a wild-type reactivation phenotype in the mouse. J. Virol. 2005, 79:12286-12295.
17. Jin L., Valentine B.A., Baker R.J., Lohr C.V., Gerlach R.F., Bildfell R.J., Moerdyk-Schauwecker M. An outbreak of fatal herpesvirus infection in domestic rabbits in Alaska. Vet. Pathol. 2008, 45:369-374.
18. Johnson D.C., Frame M.C., Ligas M.W., Cross A.M., Stow N.D. Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI. J. Virol. 1988, 62:1347-1354.
19. Kehm R., Rosen-Wolff A., Darai G. Restitution of the UL56 gene expression of HSV-1 HFEM led to restoration of virulent phenotype; deletion of the amino acids 217-234 of the UL56 protein abrogates the virulent phenotype. Virus Res. 1996, 40:17-31.
20. Knipe D.M., Smith J.L. A mutant herpesvirus protein leads to a block in nuclear localization of other viral proteins. Mol. Cell Biol. 1986, 6:2371-2381.
21. Kuddus R., Gu B., DeLuca N.A. Relationship between TATA-binding protein and herpes simplex virus type 1 ICP4 DNA-binding sites in complex formation and repression of transcription. J. Virol. 1995, 69:5568-5575.
22. Leib D.A., Bogard C.L., Kosz-Vnenchak M., Hicks K.A., Coen D.M., Knipe D.M., Schaffer P.A. A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency. J. Virol. 1989, 63:2893-2900.
23. Li Y., Zhang C., Chen X., Yu J., Wang Y., Yang Y., Du M., Jin H., Ma Y., He B., Cao Y. ICP34.5 protein of herpes simplex virus facilitates the initiation of protein translation by bridging eukaryotic initiation factor 2alpha (eIF2alpha) and protein phosphatase 1. J. Biol. Chem. 2011, 286:24785-24792.
24. Mao H. An N-terminal arginine-rich cluster and a proline-alanine-threonine repeat region determine the cellular localization of the herpes simplex virus type 1 ICP34.5 protein and its ligand, protein phosphatase 1. J. Biol. Chem. 2002, 277:11423-11431.
25. Mao H., Rosenthal K.S. Strain-dependent structural variants of herpes simplex virus type 1 ICP34.5 determine viral plaque size, efficiency of glycoprotein processing, and viral release and neuroinvasive disease potential. J. Virol. 2003, 77:3409-3417.
26. Martin D.W., Weber P.C. Role of the DR2 repeat array in the regulation of the ICP34.5 gene promoter of herpes simplex virus type 1 during productive infection. J. Gen. Virol. 1998, 79(3):517-523.
27. Norberg P., Bergstrom T., Rekabdar E., Lindh M., Liljeqvist J.A. Phylogenetic analysis of clinical herpes simplex virus type 1 isolates identified three genetic groups and recombinant viruses. J. Virol. 2004, 78:10755-10764.
28. Perng G.-C., Mott K.R., Osorio N., Yukht A., Salina S., Nguyen Q.-H., Nesburn A.B., Wechsler S.L. Herpes simplex virus type 1 mutants containing the KOS strain ICP34.5 gene in place of the McKrae ICP34.5 gene have McKrae-like spontaneous reactivation but non-McKrae-like virulence. J. Gen. Virol. 2002, 83:2933-2942.
29. Perng G.C., Dunkel E.C., Geary P.A., Slanina S.M., Ghiasi H., Kaiwar R., Nesburn A.B., Wechsler S.L. The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency. J. Virol. 1994, 68:8045-8055.
30. Perng G.C., Ghiasi H., Slanina S.M., Nesburn A.B., Wechsler S.L. The spontaneous reactivation function of the herpes simplex virus type 1 LAT gene resides completely within the first 1.5 kilobases of the 8.3-kilobase primary transcript. J. Virol. 1996, 70:976-984.
31. Perng G.C., Jones C., Ciacci-Zanella J., Stone M., Henderson G., Yukht A., Slanina S.M., Hofman F.M., Ghiasi H., Nesburn A.B., Wechsler S.L. Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science 2000, 287:1500-1503.
32. Perng G.C., Slanina S.M., Yukht A., Drolet B.S., Keleher W., Ghiasi H., Nesburn A.B., Wechsler S.L. A herpes simplex virus type 1 latency-associated transcript mutant with increased virulence and reduced spontaneous reactivation. J. Virol. 1999, 73:920-929.
33. Perng G.C., Thompson R.L., Sawtell N.M., Taylor W.E., Slanina S.M., Ghiasi H., Kaiwar R., Nesburn A.B., Wechsler S.L. An avirulent ICP34.5 deletion mutant of herpes simplex virus type 1 is capable of in vivo spontaneous reactivation. J. Virol. 1995, 69:3033-3041.
34. Polvino-Bodnar M., Orberg P.K., Schaffer P.A. Herpes simplex virus type 1 oriL is not required for virus replication or for the establishment and reactivation of latent infection in mice. J. Virol. 1987, 61:3528-3535.
35. Rixon F.J., McGeoch D.J. A 3' co-terminal family of mRNAs from the herpes simplex virus type 1 short region: two overlapping reading frames encode unrelated polypeptide one of which has highly reiterated amino acid sequence. Nucleic Acids Res. 1984, 12:2473-2487.
36. Rock D.L., Nesburn A.B., Ghiasi H., Ong J., Lewis T.L., Lokensgard J.R., Wechsler S.L. Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1. J. Virol. 1987, 61:3820-3826.
37. Scherba G., Jin L., Schnitzlein W.M., Vodkin M.H. Differential polymerase chain reaction for detection of wild-type and a vaccine strain of Aujeszky's disease (pseudorabies) virus. J. Virol. Methods 1992, 38:131-143.
38. Schipke J., Pohlmann A., Diestel R., Binz A., Rudolph K., Nagel C.H., Bauerfeind R., Sodeik B. The C terminus of the large tegument protein pUL36 contains multiple capsid binding sites that function differently during assembly and cell entry of herpes simplex virus. J. Virol. 2012, 86:3682-3700.
39. Shepard A.A., Imbalzano A.N., DeLuca N.A. Separation of primary structural components conferring autoregulation, transactivation, and DNA-binding properties to the herpes simplex virus transcriptional regulatory protein ICP4. J. Virol. 1989, 63:3714-3728.
40. Stevens J.G., Wagner E.K., Devi-Rao G.B., Cook M.L., Feldman L.T. RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science 1987, 235:1056-1059.
41. Strelow L.I., Laycock K.A., Jun P.Y., Rader K.A., Brady R.H., Miller J.K., Pepose J.S., Leib D.A. A structural and functional comparison of the latency-associated transcript promoters of herpes simplex virus type 1 strains KOS and McKrae. J. Gen. Virol. 1994, 75:2475-2480.
42. Stroop W.G., Schaefer D.C. Severity of experimentally reactivated herpetic eye disease is related to the neurovirulence of the latent virus. Invest Ophthalmol. Vis. Sci. 1987, 28:229-237.
43. Szpara M.L., Parsons L., Enquist L.W. Sequence variability in clinical and laboratory isolates of herpes simplex virus 1 reveals new mutations. J. Virol. 2010, 84:5303-5313.
44. Turner A., Bruun B., Minson T., Browne H. Glycoproteins gB, gD, and gHgL of herpes simplex virus type 1 are necessary and sufficient to mediate membrane fusion in a Cos cell transfection system. J. Virol. 1998, 72:873-875.
45. Umbach J.L., Kramer M.F., Jurak I., Karnowski H.W., Coen D.M., Cullen B.R. MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 2008, 454:780-783.
46. Umene K. Recombination of the internal direct repeat element DR2 responsible for the fluidity of the a sequence of herpes simplex virus type 1. J. Virol. 1991, 65:5410-5416.
47. Umene K. Herpes simplex virus type 1 variant a sequence generated by recombination and breakage of the a sequence in defined regions, including the one involved in recombination. J. Virol. 1993, 67:5685-5691.
48. Umene K. Cleavage in and around the DR1 element of the a sequence of herpes simplex virus type 1 relevant to the excision of DNA fragments with length corresponding to one and two units of the a sequence. J. Virol. 2001, 75:5870.
49. Umene K., Oohashi S., Yoshida M., Fukumaki Y. Diversity of the a sequence of herpes simplex virus type 1 developed during evolution. J. Gen. Virol. 2008, 89:841-852.
50. Weir J.P., Bennett M., Allen E.M., Elkins K.L., Martin S., Rouse B.T. Recombinant vaccinia virus expressing the herpes simplex virus type 1 glycoprotein C protects mice against herpes simplex virus challenge. J. Gen. Virol. 1989, 70(10):2587-2594.
51. Yamada H., Daikoku T., Yamashita Y., Jiang Y.M., Tsurumi T., Nishiyama Y. The product of the US10 gene of herpes simplex virus type 1 is a capsid/tegument-associated phosphoprotein which copurifies with the nuclear matrix. J. Gen. Virol. 1997, 78(11):2923-2931.